Concepedia

N. Tsai

NT

Statistics

Publications

3

Citations

71

H-Index

3

Active since

2010

Affiliations

St. Luke's Episcopal Hospital(Current)

University of Colorado Denver

Baylor College of Medicine

N. Tsai is an author at St. Luke's Episcopal Hospital specializing in virology, medicine, and viral hepatitis.

Top concepts

MedicineVirologyHepatitisViral HepatitisImmunologyVaccinationEpidemiologyImmunotherapyPublic HealthVaccine Development

Publications per year

2010–2016

3

Publications

3

1359 FIRST SVR DATA WITH THE NUCLEOSIDE ANALOGUE POLYMERASE INHIBITOR MERICITABINE (RG7128) COMBINED WITH PEGINTERFERON/RIBAVIRIN IN TREATMENT-NAIVE HCV G1/4 PATIENTS: INTERIM ANALYSIS FROM THE JUMP-C TRIAL

Paul J. Pockros, Dorte Møller Jensen, N. Tsai et al. · Journal of Hepatology · 2011 · 45 citations

Interim Analysis, The Jump-c Trial, Viral Hepatitis +6

2006 GI-5005 THERAPEUTIC VACCINE PLUS PEG-IFN/RIBAVIRIN SIGNIFICANTLY IMPROVES VIROLOGIC RESPONSE AND ALT NORMALIZATION AT END-OF-TREATMENT AND IMPROVES SVR24 COMPARED TO PEG-IFN/RIBAVIRIN IN GENOTYPE-1 CHRONIC HCV PATIENTS

Ira M. Jacobson, John G. McHutchison, Thomas Boyer et al. · Journal of Hepatology · 2010 · 13 citations

Vaccination, Vaccine Development, Viral Hepatitis +7

No Effect of Proton Pump Inhibitor (PPI) Use on SVR with Ledipasvir/Sofosbuvir (LDV/SOF): Real World Data from 2034 Genotype 1 Patients in the Trio Network

Nezam H. Afdhal, B. Bacon, Michael P. Curry et al. · Journal of Hepatology · 2016 · 13 citations

Trio Network, Genetic Epidemiology, Antiviral Therapy +7

Rows per page

1–3 of 3